ContraFect Announces Agreement With The Rockefeller University for New Staph Lysin
21 sept. 2011 09h13 HE | ContraFect Corporation
NEW YORK, NY--(Marketwire - Sep 21, 2011) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug-resistant bacteria, announced that it...
ContraFect Announces Appointment of Sol Barer to Board of Directors
22 févr. 2011 09h12 HE | ContraFect Corporation
NEW YORK, NY--(Marketwire - February 22, 2011) - ContraFect Corporation announced today that Sol Barer, Ph.D. has joined the company's Board of Directors. Dr. Barer has been the principal...
CEO Robert Nowinski Announces ContraFect Leases Laboratory and Office Space
14 déc. 2010 09h12 HE | ContraFect Corporation
NEW YORK, NY--(Marketwire - December 14, 2010) - ContraFect Corporation, the Company that is pioneering the use of Monoclonal Antibodies and Lysins for the treatment of life-threatening infectious...
ContraFect CEO Robert Nowinski Announces Agreement With The Rockefeller University to Commercialize Eight Patents Covering Bacterial Treatments
18 nov. 2010 09h12 HE | ContraFect Corporation
NEW YORK, NY--(Marketwire - November 18, 2010) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug resistant bacteria, announced that it...
ContraFect Completes $14 Million Financing
26 oct. 2010 09h12 HE | ContraFect Corporation
NEW YORK, NY--(Marketwire - October 26, 2010) -  ContraFect Corporation, the company that is pioneering the use of monoclonal antibodies and lysins for the treatment of life-threatening...